Descemet Membrane Endothelial Keratoplasty in Asian Eyes

Purpose of ReviewDescemet membrane endothelial keratoplasty (DMEK) has become the treatment of choice for endothelial diseases such as Fuchs endothelial corneal dystrophy (FECD), especially in the United States and Europe. In this review, we give an overview of current knowledge about DMEK in Asian eyes and describe novel surgical modifications of this technique for these cases.Recent FindingsAlthough many scientific reviews about DMEK in Caucasian eyes have already been published, there is still little knowledge about clinical outcomes of DMEK in Asian eyes. This is of particular importance, as there are substantial differences between DMEK in Asian and Caucasian eyes. Bullous keratopathy is the main indication for endothelial keratoplasty in Asia, whereas it is FECD in Caucasian countries. Considering etiological and anatomical differences, we have adapted DMEK for Asian eyes and have developed several technical modifications to improve clinical outcome. SummaryOur work might be helpful in performing successful DMEK in the Asian setting.